Pernix Therapeutics Holdings, Inc.
PTX
PTX was delisted on the 4th of March, 2019.
30 hedge funds and large institutions have $7.93M invested in Pernix Therapeutics Holdings, Inc. in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 5 closing their positions.
140% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 5
24% more capital invested
Capital invested by funds: $6.4M → $7.93M (+$1.53M)
7% less call options, than puts
Call options by funds: $1.31M | Put options by funds: $1.41M
3% less funds holding
Funds holding: 31 → 30 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$259K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$245K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$210K |
| 4 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$204K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$171K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$94K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$86.9K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
-$39K |
| 4 |
Bank of New York Mellon
New York
|
-$31.2K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$29.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Wolverine Trading
Chicago,
Illinois
| – | -$39K | -10,585 | Closed |
|
|
FPF
27
FNY Partners Fund
New York
| – | -$1K | -500 | Closed |
|
|
CG
28
Cutler Group
San Francisco,
California
| – | -$1.61K | -369 | Closed |
|
29
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| – | -$74 | -17 | -17% |
|
PTX Hedge Fund Activity: Q2 2017 in Review
30 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q2 2017, worth a combined $7.93M — up 24% from $6.4M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PTX and 4 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 12 added.
The largest buyer was Renaissance Technologies, adding an estimated $259K. The largest seller was Goldman Sachs, exiting entirely with an estimated $94K sold.
- 30 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q2 2017, down from 31 in Q1 2017.
- Funds reported $7.93M of Pernix Therapeutics Holdings, Inc. stock for Q2 2017, up 24% quarter-over-quarter.
- 4 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q2 2017 and 5 closed out, a net change of -1 holder.
- The largest Pernix Therapeutics Holdings, Inc. buyer in Q2 2017 was Renaissance Technologies, an estimated $259K added.
- The largest Pernix Therapeutics Holdings, Inc. seller in Q2 2017 was Goldman Sachs, an estimated $94K sold.
Based on aggregated 13F filings for Q2 2017.